跳至主要内容
临床试验/NCT01056120
NCT01056120已完成不适用

Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice Multinational, Prospective, Non-randomized, Multi-centre, Non-interventional Trial

Biotronik AG50 个研究点 分布在 10 个国家目标入组 1,026 人开始时间: 2010年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Biotronik AG
入组人数
1,026
试验地点
50
主要终点
MACE (Cardiac death, clinically driven TLR, MI / AMI (STEMI / NSTEMI)

研究概览

简要总结

To evaluate the clinical performance of the PRO-Kinetic ENERGY® coronary bare metal stent system in a patient population within that defined in the Instructions for Use.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient signed informed consent for data release
  • Patient eligible for percutaneous coronary intervention (PCI)
  • De novo and re-stenosed coronary artery lesions
  • Patient is geographically stable and willing to participate at all follow up assessments
  • Patient is > 18 years of age

排除标准

  • Patient receives more than one stent, which is not a PRO-Kinetic ENERGY stent within the same vessel
  • Patient has a known allergy against aspirin, clopidogrel, ticlopidine, heparin or any other anticoagulation / antiplatelet therapy required for PCI
  • Patient presents with ISR (in-stent restenosis)

结局指标

主要结局

MACE (Cardiac death, clinically driven TLR, MI / AMI (STEMI / NSTEMI)

时间窗: 6 months

次要结局

  • • MACE after 12 and 24 months • TVR after 6, 12 and 24 months • Stent Thrombosis at 6, 12 and 24 months acc. to the academic research consortium -ARC (13)(6,12, 24 Months)

研究者

发起方
Biotronik AG
申办方类型
Industry
责任方
Sponsor

研究点 (50)

Loading locations...

相似试验